[Ala10]-beta-Amyloid (1-10) is a truncated version of the amyloid-beta peptide with an alanine substitution at position 10, which affects aggregation and fibril formation. This analog is used to investigate early stages of amyloid aggregation and its role in neurodegenerative diseases. Researchers use it to study the effects of sequence modifications on the peptide's structure and its impact on neurotoxicity.
CAT No: A13019
2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
5. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More